• N/A
    Market Cap
  • 48.76%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: N/A
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

No data found

No data found

Peers

Statistics

More
Day Range
$0.18
$0.18
$0.18
1-Year Range
$0.13
$0.28
$0.18
Latest Close$0.18
Change
-$0.005 (-2.78%)
Volume2,500
Shares Outstanding8.1M
P/E (TTM)-4.29
Diluted EPS (TTM)-$0.04

Information as of 10/27/2026

Company Profile

N/A
Market Cap
-$341,140.00
Net Income
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
164 Douglas Rd, Oldsmar, FL, United States, 34677
727 447 2998

Procyon Corporation, together with its subsidiaries, engages in manufacturing and marketing of wound and skin care products in the United States. The company offers skin and wound care products made with antimicrobial agent under the AMERIGEL hydrogel wound dressing, AMERIGEL post-op surgical kit, AMERIGEL saline wound wash, AMERIGEL care lotion, and AMERIGEL barrier lotion names, as well as EXTREMIT-EASE name. It also provides HELIX3-CP Collagen Powder and HELIX3-CM Collagen Matrix; AMERX wound care kits, AMERX calcium alginate dressings, AMERX foam dressings, AMERX bordered foam dressings, AMERX bordered gauze dressings, AMERX hydrocolloid dressings, and AMERX thin hydrocolloid dressings; and Oakin, which provides healing in wound and problematic skin conditions. The company serves physicians, healthcare providers, hospitals, clinics, institutions, and schools. Procyon Corporation was incorporated in 1987 and is based in Oldsmar, Florida.

Key Executives

  • Justice W. Anderson
  • James Anderson
  • George Otis Borak

Current Ownership Distribution

  • Insiders7.4M (90.92%)
  • Mutual Funds385,629 (4.75%)
  • Other351,821 (4.33%)
  • Institutions0 (0.00%)